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Summary.-The action of methotrexate, actinomycin D, bleomycin, vincristine and
hydroxyurea on the production of human chorionic gonadotrophin (hCG) by a
choriocarcinoma cell line (BeWo) has been studied. hCG production per unit of cell
protein was increased, and this was a continuing process only halted by cell death.
The proportion of hCG-producing cells in the population increased from -5% to a
maximum of ~40O% during incubation with vincristine. A possible explanation for
these and related observations is that cytotoxic agents promote the differentiation of
cytotrophoblast to syncytium. A similar mechanism could contribute to the unusual
sensitivity of choriocarcinoma to cytotoxic agents.
HUMAN CHORIONIC GONADOTROPHIN
(hCG) is synthesized by the syncytiotro-
phoblastic cells of the placenta and of
trophoblastic tumours. It is also known to
be synthesized in small amounts by some
other tissues, and by a variety of non-
trophoblastic tumours (Bagshawe et al.,
1979). hCG consists of two different non-
covalently linked subunits. Measurement
of serum or urine hCG by immunoassay
using antisera directed at the a-subunit is
standard practice in the management of
both gestational and non-gestational tro-
phoblastic tumours, which are unusually
responsive to cytotoxic agents.
The administration of effective cyto-
toxic therapy to a patient with chorio-
carcinoma commonly increases the serum
and urine hCG concentrations which
remain high for several days before values
fall, and it has been suggested that the
initial peak might be due to lysis of cells
releasing preformed hCG. Several reports
have indicated that when choriocarcinoma
cells growing in vitro are exposed to
certain cytotoxic agents, the amount of
hCG secreted into the medium is greatly
increased (Hussa et al., 1973; Speeg et al.,
1976). Moreover, it has been shown that
this is due to increased hormone synthesis,
and is not attributable to cell lysis. In
vitro studies of choriocarcinoma cells
show that only a small fraction ofthe total
population is secreting hCG at any time,
and in vivo the hCG-secreting syncytio-
trophoblastic cells are end-stage cells in
which mitotic figures are rarely seen.
Increased hCG synthesis could result
from greater output/cell/unit time. If, on
the other hand, it resulted from an in-
creased proportion of hCG-synthesizing
cells in the population, it would have
important implications for the possible
mode of action of cytotoxic agents on
trophoblastic tumours.
The present investigation therefore at-
tempted to assess the capacity ofcytotoxic
agents that are used in the treatment of
choriocarcinoma to stimulate hCG secre-
tion in the choriocarcinoma cell line
BeWo (Pattillo & Gey, 1968), to determine
the duration of this stimulation and to
relate this to the number of cells present.
MATERIALS AND METHODS
Materials
Methotrexate (AITX) was obtained firomil
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omycin-D (AD) from Merck, Sharp and
Dohme, bleomycin (BLM) from Lundbeck,
vincristine sulphate (VCR) from Eli Lilly and
hydroxyurea (HU) from B.D.H. Normal
swine serum, swine anti-rabbit-IgG serum
and peroxidase/rabbit anti-peroxidase com-
plexes were obtained from Dako.
Methods
BeWo cells, kindly provided by Dr
Roland Pattillo, Department of Obstetrics
and Gynaecology, Medical College of Wis-
consin, Milwaukee, Wis., were grown in
RPMI 1640 (GIBCO) supplemented with 10%
(v/v) foetal calf serum and penicillin (100
u/ml) and streptomycin (100 pg/ml).
To determine the effects of antimetabolites
on hCG production, the cells were harvested
from monolayer culture with a trypsin-
EDTA solution (0.5% trypsin 1:250 and
0.2% EDTA in normal saline) and their con-
centration adjusted to 2-0 x 105/ml. This cell
suspension was added to multi-well plates
(Sterilin product No. 313) at 1P5 ml/well and
the cells allowed to attach for 24 h. The
medium was removed, and to each well was
added 1-5 ml of fresh culture medium (con-
trol) or medium containing MTX, AD, BLM,
VCR or HU. At intervals thereafter the
medium was collected from each well and
fresh antimetabolite solutions added. The
collected medium was centrifuged to remove
particulate material and stored at - 20°C for
subsequent radioimmunoassay.
Cell protein was determined by the Lowry
method using bovine serum albumin as
standard. The cell monolayers were washed
x 3 with normal saline and stored at - 20°C
until they could be conveniently assayed.
Then 5 ml ofLowry's solution C was added to
each well to dissolve the cells. To assist
dissolution the monolayers were scraped with
a rubber policeman.
Radioimmunoassay ofhCG.-The concentra-
tion of hCG-reactive material in unfraction-
ated culture medium was measured by a
double-antibody radioimmunoassay (Kard-
ana & Bagshawe, 1976) in which primary and
secondary antibodies were preincubated, the
standard was intact hCG labelled with 1251 by
the chloramine-T method and the assay
incubation time was 18 h at 37°C. Assay
sensitivity was 2-4 mIU/ml. The primary
antiserum was raised by injecting rabbits
with purified , subunit of hCG. This anti-
serum displayed less than 10% cross-
reactivity with human luteinizing hormone.
To every assay tube 100/l of culture
medium was added, so that nonspecific
effects due to differences in pH, osmolarity or
protein concentration between culture medi-
um and the assay buffer were eliminated.
None of the antimetabolites used interfered
with the radioimmunoassay.
The culture media were also subjected to
radioimmunoassay for the syncytiotropho-
blastic proteins, human placental lactogen
and pregnancy-specific B1SP glycoprotein. At
no stage in the control or drug-treated
cultures were these proteins detected.
Immunocytochemical demonstration of hCG.
-BeWo cells growing in monolayer culture
were washed in PBS (pH 7.5), fixed for 30
min in neutral buffered formalin, washed
again in PBS, and allowed to dry. A 30 min
pre-incubation in PBS containing 20% (v/v)
normal swine serum was followed by a 30 min
incubation with rabbit anti-hCG diluted in
PBS+20% normal swine serum. After wash-
ing with PBS the cells were incubated for 30
min with swine anti-rabbit-IgG, washed
again and incubated with peroxidase/rabbit
anti-peroxidase complexes for 30 min. Finally,
the cells were washed and incubated for 5
min in PBS containing 0.05% (w/v) 3,3-
diaminobenzidine tetrahydrochloride and
0.01% (v/v) hydrogen peroxide. After stain-
ing with haematoxylin the percentage of
positively stained cells was determined.
Rabbit anti-hCG preincubated with hCG
was used as a control for the specificity ofthe
staining reaction. This gave a negative
reaction with the cells.
RESULTS
All the cytotoxic agents tested had
similar effects on BeWo hCG production.
Fig. 1(a-e) shows that these drugs stimu-
lated a dose-dependent increase in the
amount of hCG released into the culture
medium. This increase reached a peak
between 2 and 6 days of incubation, after
which hCG levels fell away to less than
control values.
A somewhat different picture was ob-
tained if hCG secretion was related to cell
number or cell protein. It was thought that
cell protein would be a better measure of
drug effect than cell number. because the
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FiG. 1.-Stimulation of hCG secretion by
antimetabolites. BeWo cells were sub-
cultured 24 h before incubation with medi-
um only (control) or medium containing
MTX, AD, BLM, VCR or HU. Media were
replaced with fresh solutions after 1, 2, 3, 6
and 9 days ofincubation. Each point repre-
sents the mean concentration ofhCG meas-
ured in the medium from triplicate cultures,
expressed as a percentage of the mean hCG
concentration of sextuplicate control cul-
tures (= 100%).
amount of protein per cell may vary with
drug treatment. Also, with near-confluent
BeWo cultures it is difficult to distinguish
individual cells, so that to enumerate cells
in such cultures it is necessary to trypsin-
ize and count them in suspension. Whilst
this gave reasonable results with healthy
cultures, it was found that the drug-
treated cells, especially after several days'
incubation, were too readily lysed by
trypsin.
It can be seen from Fig. 2 that the
amount of hCG secreted per unit of cell
protein increased throughout the period of
incubation with VCR and HU. After 12
days' incubation, cell protein was un-
detectable in the VCR- and in the HU-
treated cultures, though low butsignificant
levels of hCG were measured. At this time
very few viable (i.e. adherent) cells could
be seen.
6
4
2
2 4 6 8 10 12
DAYS OF INCUBATION
FIG. 2. Stimulation of hCG secretion by VCR
and HU, related to total cell protein. BeWo
cells were subcultured 24 h before incuba-
tion with medium only (0) or medium con-
taining 10-6MVCR (A) or 10-2M HU (0).
These media were replaced with fresh solu-
tions every 2 days. After 2, 4, 6, 8, 10 and
12 days of incubation, the media were
collected for hCG radioimmunoassay and
the cell monolayers were assayed for total
protein. Each point represents the mean of
triplicate cultures.
Thus stimulation of hCG production in
vitro, rather than being a transitory
phenomenon associated with the early
stages of incubation with a cytotoxic
agent, is essentially a continuing process
which is only halted by cell death.
The effect of the 5 agents on total cell
protein varied with dose. Taking those
drug concentrations optimal for enhance-
ment of hCG production (10-6-10-8M for
MTX, 10-8M for AD. 10 ,ug/ml for BLM,
25
u -P. BROWNE AND K. D. BAGSHAWE
10-6-10-7M for VCR and 10-2M for HU)
with all 5 agents there was an initial period
during which levels of cell protein per
culture rose, though at a lower rate than
in the control cultures, but as incubation
continued cell protein levels fell and there
was a corresponding increase in cell
debris. The duration ofthe period in which
cell protein was increasing differed be-
tween the drugs, being greatest with
MTX. Indeed with 10-7 and 10-8M MTX,
no decrease was observed, that is, cell
protein continued to increase throughout
the incubation, while with 10-6M MTX
cell protein did not begin to decrease until
after 9 days of incubation. With 10-6M
VCR and 10-8M AD, cell protein declined
from Day 2 of incubation whilst with
10jig/ml BLM and 1O-2M HU, levels began
to fall from Day 3 of incubation. BeWo
cell protein was undetectable after 9 days'
incubation with 10-8M AD, after 10 days
with 1O-2M HU and after 12 days' incuba-
tion with 1O-6M VCR. From this it may be
deduced that enhancement of hCG pro-
duction is obtained at drug concentrations
which, though not immediately cytotoxic,
eventually lead to cell death.
Immunocytochemicat demonstration of hCG
BeWo cultures were incubated for 3
days with various concentrations of VCR
TABLE-.Effect of VCR on proportion of
cetls containing hCG
VCR
conen.
(M)
0
10-4
10-5
10-6
10-7
10-8
10-9
hCG/culture/24 1h*
(mIU)
196 -4
377 - 7
736 - 9
951-0
1138-3
866 - 5
443 - 2
hCG+ cellst
(0)
4-3+ 1-7
3 7+0 5
11*2+ 3-5
31- 5 + 3 -4
39 * 9 + 8 - 4
22 - 2 + 5 - 0
20-2+6-3
BeWo cells were subcultured 24 Ii before incuba-
tion for 72 h with medium containing various con-
centrations of VCR or medium only. The medium
with or without VCR, was changed every 24 h. At
72 h, the medium was collected and assayed for hCG,
and the cells in each culture were stained for hCG by
the immunoperoxidase method.
* Total amount secreted into medium between 48
and 72 h of incubation
t Each value is the mean 0O (+s.d.) of hCG+ cells
in 4 areas of a single culture.
and then stained for hCG. All cells showing
discernible brown staining were classed as
hCG+. Results are displayed in the Table,
where it can be seen that incubation with
VCR increased the percentage of hCG+
positive cells, and that the concentration
of VCR stimulating the greatest increase
in culture-medium hCG levels was also
that which produced the greatest per-
centage of hCG+ cells.
DISCUSSION
Attention has been paid to the regula-
tion of hCG synthesis in cultured chorio-
carcinoma cells (Hussa et al., 1973, 1977;
Speeg et al., 1976; Azizkhan et al., 1979)
and in other cell lines such as HeLa which
ectopically produce subunits of hCG
(Ghosh et al., 1977; Fallon & Cox, 1979).
There is now a large body of data on the
manner in which this synthesis is stimu-
lated by agents which otherwise inhibit
cell metabolism, though as yet no convin-
cing explanation has been advanced to
account for this stimulation.
That a variety of cytotoxic agents with
different modes of action were found to
stimulate hCG synthesis suggests that, if a
common biochemical lesion is involved, it
must be of a very general nature. How-
ever, this stimulation is not simply an
effect of agents which are toxic to BeWo
cells (Hussa et al., 1973). Indeed, as the
dose-dependence of the phenomenon sug-
gests, excessive toxicity may prevent the
enhancement ofhormone production. Also,
dibutyryl cyclic AMP, but not equimolar
cyclic AMP, stimulates hCG synthesis
(Hussa et al., 1977), though the latter is
apparently a greater inhibitor of BeWo
growth, and produces more cell death
(Barker & Isles, 1977).
A stimulator must therefore have a
relatively selective effect on cell function.
Attention has been drawn to the correla-
tion between inhibition of DNA synthesis
and stimulation of hCG production. Aziz-
khan et al. (1979) have reported that
removal of hCG-inducing antimetabolites
from JAr cultures (another hCG-synthe-
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sizing trophoblastic cell line) causes less
enhancement of hCG synthesis, which is
chronologically related to disinhibition of
DNA synthesis. However, the mechan-
ism(s) relating inhibition of DNA syn-
thesis to enhanced hCG production are
unknown. One possibility which has been
mooted is that hCG-inducing antimetabol-
ites may arrest cycling cells in a phase of
the cell cycle at which hCG synthesis is
maximal (Speeg et al., 1976; Azizkhan et
al., 1979).
Fallon & Cox (1979) have shown that
the hCG-inducer sodium butyrate arrests
HeLa cells nearthe G1/S-phase boundary.
Alternatively, it can be suggested that
in the BeWo line, and perhaps in chorio-
carcinoma cell lines in general, hCG
synthesis is not restricted to a specific
stage ofthe cell cycle, but is accomplished
by specialized end-cells.
In BeWo cultures, 2 cell types may be
recognized. The great majority are small
mononucleate cells which undergo cell
division. These can be considered as
cycling cells, and by analogy with the
placenta they have been termed cyto-
trophoblast-like cells. A small proportion
of cells are large, non-proliferative and
often multinucleate. These have been
called syncytiotrophoblast-like cells
(Friedman & Skehan, 1979).
In the placenta the syncytiotrophoblast
is formed from the cytotrophoblast, ap-
parently by cell fusion, and further cell
division does not appear to occur. With
immunocytochemical techniques, hCG ap-
pears to be localized to the syncytial cells
(Midgley & Pierce, 1962; de Ikonicoff &
Cedard, 1973) and in trophoblastic tum-
ours the situation appears to be similar.
When we have stained choriocarcinomas
by the immunoperoxidase technique, hCG
appears to be confined to large syncytial
cells (unpublished observations) and this
is in line with the results ofothers (Midgley
& Pierce, 1962; Kameya et al., 1977).
Against this there are reports that hCG can
be localized to cytotrophoblastic cells, as
well as the syncytiotrophoblast, in pla-
centa (Hoshina et al., 1979) and in chorio-
carcinomas (Gartner et al., 1975). How-
ever, it is recognized that immunocyto-
chemical techniques are vulnerable to
nonspecific effects. Furthermore, it may be
that hCG synthesis is switched on early in
the process of differentiation, while cells
still possess some or all of the morpho-
logical features of cytotrophoblast.
It remains to be definitely established
that syncytiotrophoblastic cells in chorio-
carcinoma cultures are solely responsible
for hCG synthesis.
Friedman & Skehan (1979) have found
that 1-4% of the cells in BeWo cultures
are syncytiotrophoblastic. The immuno-
cytochemical demonstration of hCG re-
ported on here indicates that at one stage
in normal cultures about 4% of the cells
contain detectable hCG+ material. How-
ever, under the conditions used for viewing
the stained cells it was not possible to
distinguish between cell types.
Yorde et al. (1979) have used the im-
munoperoxidase technique to stain BeWo
cells for hCG at the light- and electron-
microscopic levels. They reported a similar
though slightly higher percentage of
hCG+ cells. It is interesting that they
obtained a good correlation between the
percentages of cells hCG+ by light and
electron microscopy. This suggests that
failure to stain 95% of the cells results
from a real absence of hormonal subunits,
rather than from a technical lack of
sensitivity. In addition they found that
dibutyryl cyclic AMP with theophylline
increased the percentage of hCG subunit-
containing cells and that this correlated
very well with an increase in secreted
hCG.
Friedman & Skehan (1979) have re-
ported that incubating BeWo cells with
1O-6M MTX, a dose which stimulates hCG
production, increases the population of
syncytiotrophoblastic cells. It may there-
fore be suggested that differentiation of
cytotrophoblastic to syncytiotrophoblastic
cells in choriocarcinoma cultures is trig-
gered by a variety ofcytotoxic agents, and
that one result of this differentiation is
increased hCG output.
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Midgley & Pierce (1961) have reported
on the effect of colchicine on a xeno-
grafted human embryonal carcinoma.
They found that colchicine produced an
increased incidence of hCG secretion by
the tumour, together with an increase in
the number of cells in the tumour morph-
ologically similar to syncytiotrophoblastic
giant cells of choriocarcinoma.
It is possible therefore that interference
by cytotoxic agents with DNA synthesis in
choriocarcinoma cells, both in vivo and in
vitro, increases the rate of formation of
syncytial cells and correspondingly re-
duces the cytotrophoblastic cells. As a
consequence of this differentiation, hCG
synthesis increases and remains high on an
output/cell or unit protein basis. Cell
numbers subsequently diminish, since
syncytial cells, apart from any cytotoxic
effects, have limited survival.
This suggests the hypothesis that the
unusual sensitivity of trophoblastic tum-
ours to agents inhibiting DNA synthesis
may be due at least in part to the promo-
tion of differentiation to short-lived end-
cells.
The intra-tumour drug concentrations
that are achieved in choriocarcinoma
patients on chemotherapy are not known.
Consequently it is difficult to relate the
optimal hCG-enhancing doses, derived
from our in vitro studies, to the clinical
situation. The peak blood concentrations
that occur with conventional chemothera-
peutic dose schedules may be looked at.
There are studies on patients undergoing
chemotherapy in which the peak plasma
concentrationsofMTX(Chabner, 1979),AD
(Tattersall et al., 1975), BLM, (Teale et al.,
1977), VCR (Bender et al., 1977) and HU
(Belt et al., 1980) are, albeit transiently
within an orderofmagnitudeofthe concen-
trations of these agents which we found
optimally enhanced BeWo hCG produc-
tion in vitro. Obviously intra-tumour drug
levels will differ from plasma levels, but
the studies referred to do at least indicate
that the optimum in vitro concentrations
are not wildly different from those that
occur in patients receiving chemotherapy.
This work was supported by the Cancer Research
Campaign.
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